NIR Fluorescent Imaging and Photodynamic Therapy with a Novel Theranostic Phospholipid Probe for Triple-Negative Breast Cancer Cells
Authors:
- 17 June 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 32 (8) , 1852-1863
Abstract
New exogenous probes are needed for both imaging diagnostics and therapeutics. Here, we introduce a novel nanocomposite near-infrared (NIR) fluorescent imaging probe and test its potency as a photosensitizing agent for photodynamic therapy (PDT) against triple-negative breast cancer cells. The active component in the nanocomposite is a small molecule, pyropheophorbide a-phosphatidylethanolamine-QSY21 (Pyro-PtdEtn-QSY), which is imbedded into lipid nanoparticles for transport in the body. The probe targets abnormal choline metabolism in cancer cells; specifically, the overexpression of phosphatidylcholine-specific phospholipase C (PC–PLC) in breast, prostate, and ovarian cancers. Pyro-PtdEtn-QSY consists of a NIR fluorophore and a quencher, attached to a PtdEtn moiety. It is selectively activated by PC–PLC resulting in enhanced fluorescence in cancer cells compared to normal cells. In our in vitro investigation, four breast cancer cell lines showed higher probe activation levels than noncancerous control cells, immortalized human mammary gland cells, and normal human T cells. Moreover, the ability of this nanocomposite to function as a sensitizer in PDT experiments on MDA-MB-231 cells suggests that the probe is promising as a theranostic agent.Keywords
Funding Information
- National Cancer Institute (F31-CA206453, R01-CA201328, R01-CA226412)
- National Institute of Neurological Disorders and Stroke (R01-NS100892)
- University of Pennsylvania
This publication has 77 references indexed in Scilit:
- Triple‑negative breast cancer therapy: Current and future perspectives (Review)International Journal of Oncology, 2020
- The role of phosphatidylcholine and choline metabolites to cell proliferation and survivalCritical Reviews in Biochemistry and Molecular Biology, 2013
- Choline metabolism in malignant transformationNature Reviews Cancer, 2011
- Modulation of Photosensitization Processes for an Improved Targeted Photodynamic TherapyCurrent Medicinal Chemistry, 2010
- Triple-negative breast cancer: disease entity or title of convenience?Nature Reviews Clinical Oncology, 2010
- Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2005
- Pathologic Characterization of Human Prostate Tissue with Proton MR SpectroscopyRadiology, 2003
- Three-Dimensional Magnetic Resonance Spectroscopic Imaging of Brain and Prostate CancerNeoplasia, 2000
- Tumour phospholipid metabolismNMR in Biomedicine, 1999
- Studies of human tumors by MRS: A reviewNMR in Biomedicine, 1992